ArticleImmune network2020

Baseline Serum Interleukin-6 Levels Predict the Response of Patients with Advanced Non-small Cell Lung Cancer to PD-1/PD-L1 Inhibitors.

Da Hyun Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.